Skip to content

Clinical trials

Myeloproliferative Disorders trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Phase: Not applicable Country / region: United States Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20012
20022
20034
20043
20053
20062
20073
20082
20092
20103
20121
20132
20141
20171
20181
20201
20213
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Terminated10
Recruiting4
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center7
University of California, San Francisco3
Baylor College of Medicine2
Case Comprehensive Cancer Center2
City of Hope Medical Center2
Masonic Cancer Center, University of Minnesota2
Massachusetts General Hospital2
OHSU Knight Cancer Institute2
Roswell Park Cancer Institute2
Stanford University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders48
Hodgkin Disease34
Precursor Cell Lymphoblastic Leukemia-Lymphoma34
Lymphoma, Non-Hodgkin33
Leukemia, Myeloid, Acute31
Multiple Myeloma31
Primary Myelofibrosis31
Leukemia, Lymphocytic, Chronic, B-Cell30
Lymphoma, Mantle-Cell29
Lymphoma, Follicular28

Trials

Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.